Kibow Biotech, Inc.
4781 West Chester Pike
Newtown Square
Pennsylvania
19073
United States
Tel: 215-966-6170
Fax: 215-966-6168
Website: http://www.kibowbiotech.com/
Email: info@kibowbiotech.com
40 articles about Kibow Biotech, Inc.
-
KIBOW Celebrates 25 Years of Microbiome R&D Focusing on CKD Patients
9/30/2022
Kibow Biotech, Inc., a clinical-stage biotechnology company developing live biotherapeutics that target the dysbiosis in patients with CKD, celebrated a 25-year legacy of dedication to improving the lives of patients with kidney disease.
-
Kibow Biotech Announces FDA Approval of IND to Initiate Phase II Clinical Trial of US-APR2020 to Treat Chronic Kidney Disease Stage IV
4/13/2021
Kibow Biotech, Inc., today announced that the U.S. Food and Drug Administration (FDA) had approved the Company's Investigational New Drug Application (IND) for US-APR2020 to treat patients with Chronic Kidney Disease (CKD) stage IV.
-
Kibow Biotech Supports World Kidney Day 2021
3/11/2021
Kibow Biotech is pleased to support World Kidney Day's "global campaign to raise awareness of the importance of our kidneys to overall health and to reduce the frequency and impact of kidney disease and associated health problems worldwide." Kibow will mark World Kidney Day, March 11, 2021, with a significant social media campaign to increase awareness of the importance of maintaining kidney function and remembering the kidney transplant shortage that affects patients worldwide.
-
Kibow Biotech Celebrates its 23rd Anniversary with the Launch of Ultimate Heart Health Probiotic Kibow Cardio Support™
10/19/2020
Kibow Biotech, a pioneering innovator in scientifically formulated and clinically tested probiotic dietary supplements, internationally renowned for its kidney health supplements Renady l ™ and Azodyl ®, announced today that it has released Kibow Cardio Support ™ for sale to the general public in celebration of i
-
Kibow® Biotech Supports World Kidney Day and The Recently Formed KidneyX Program
3/12/2020
Kibow Biotech is pleased to announce that it will mark World Kidney Day, March 12, 2020, with a significant social media campaign to encourage the importance of maintaining kidney function and remembering the kidney transplant shortage that affects patients worldwide.
-
Kibow® Biotech Inc Celebrates Its 22nd Anniversary with Launch of Its Pharmaceutical Division to Develop a Live Biotherapeutic Drug for Chronic Kidney Disease Patients Based on Its Novel "Enteric Dialysis® Technology Platform
10/1/2019
Kibow® Biotech Inc, a pioneering probiotic company in gut modulation with its novel "Enteric Dialysis®" technology platform, is celebrating its 22-year anniversary on October 1st, 2019.
-
Kibow Biotech to Showcase Flagship Product, Renadyl™ for Kidney Health, and Celebrate "100 Years of Licensure" at the 2019 American Association of Naturopathic Physicians Convention in Portland, Oregon
8/14/2019
Kibow® Biotech, Inc. is excited to feature RENADYL™, an all-natural probiotic formulation for kidney health, during the 2019 The American Association of Naturopathic Physicians Convention from August 15-17 at the Oregon Convention Center.
-
Kibow Biotech Will Discuss RENADYL™, the World's First and Only Probiotic to Help Maintain Healthy Kidney Function, at the AADE Conference in Houston, Texas
8/7/2019
Kibow® Biotech, Inc. will feature its RENADYL™, its proprietary probiotic for kidney health, at the 2019 American Association of Diabetic Educators (AADE) Conference from August 8-11 at the George R. Brown Convention Center in Houston, Texas.
-
Kibow® Biotech Inc Supports President Trump's Executive Order to Advance American Kidney Health with Expanded Plans to Develop Live Bio Therapeutic Product (LBP) as Drugs to Slow Progression to Dialysis
7/24/2019
As a pioneer in the Enteric Dialysis® platform technology, Kibow® Biotech's mission has always been in conjunction with the standard care of therapy
-
Kibow Biotech will Discuss RENADYL™, the World's First and Only Use of Probiotics to Support Kidney Health at the 2019 National Kidney Foundation Spring Clinical Meeting in Boston, MA USA, May 9-12, 2019
5/6/2019
Kibow Biotech is the pioneer in the study of the "Gut Microbiome," and the use of beneficial bacteria (probiotics) for a variety of serious illnesses.
-
Kibow Biotech will present RENADYL™ at the 2019 American Nephrology Nurses Association (ANNA) in Dallas, Texas, USA, April 14-16, 2019
4/12/2019
Kibow Biotech, Inc., Pennsylvania, will feature its product for Kidney Illness, RENADYL™, at the 50th Anniversary Meeting of the American Nephrology Nurse Association (ANNA) in Dallas, Texas, USA. (www.annanurse.org)
-
Kibow Biotech, Inc. Presents its Latest Findings Highlighting Removal of Large Concentrations of Urea Besides Several Other Uremic Toxins Using Renadyl™ in CKD Applications at the ISN/WCN Conference in Melbourne, Australia, April 12-15, 2019
4/11/2019
We are proud to be presenting our latest abstract which combines over 20 years of research while supporting of our company's core business principal: modulation of gut microbiome using pro and prebiotics, for various health conditions.
-
Indian High Court in Chennai Delivers a Decisive Product Patent Victory to Kibow Biotech Inc Specializing in Kidney Health Supplement "Renadyl™" - the Flagship Product for its "Enteric Dialysis®" Platform Technology
2/22/2019
Kibow Biotech Inc is pleased to announce that it has achieved a significant victory with its India patent in a lawsuit brought by La Renon an Ahmedabad based company. [Patent No. 351/MUMNP/2006, 224100 "Compositions for Augmenting Kidney Function" Patent No. 224100, - issued September 29, 2008].
-
Kibow Biotech to Exhibit Its "Enteric Dialysis®" Technology and Renadyl™ to Delay the Need for Hemo/Peritoneal Dialysis at the 15th Annual Integrative Health Symposium (IHS), New York, NY
2/19/2019
Kibow Biotech is proud to announce its 22nd year of operations and that it is the pioneer with the use of Pro/Prebiotics in people with failing kidneys.
-
Kibow Biotech to Exhibit Its "Enteric Dialysis®" Technology and Renadyl™ to Delay The Need For Hemo/Peritoneal Dialysis at the Annual ASN 2018 - Kidney Week Conference
10/23/2018
Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people with failing kidneys. Kibow has been participating and exhibiting at the annual meeting of the American Society of Nephrology being held from Oct 22–28, San Diego, CA.
-
Kibow Biotech to Present Its Breakthrough and Proven "Enteric Dialysis®" Technology at BIO 2018 International Convention, June 4-7 in Boston, MA, USA
6/4/2018
Kibow Biotech is pleased to have been invited to present its breakthrough "Enteric Dialysis®" Technology at BIO 2018 International Convention.
-
Kibow Biotech to Participate in The Pediatric Academic Societies (PAS) 2018 Meeting, May 5-8, 2018 in Toronto, Canada
5/4/2018
Kibow Biotech is pleased to be exhibiting for the first time at The Pediatric Academic Societies (PAS) Meeting, May 5-8, 2018 in Toronto, Canada
-
Revolutionary, Non-Invasive, Cost Effective Renal Technology Working 24/7 Shows It Helps Maintain Healthy Kidney Function
10/24/2017
For 20 years, Kibow Biotech has been refining a novel approach to maintaining healthy kidney function "Enteric Dialysis". Enteric Dialysis utilizes probiotics (yes, probiotics) to metabolize the waste products (toxins) building up in the bloodstream due to reduced kidney function.
-
Kibow Biotech, Inc. (Buzz Of Bio Winner, 2014) Receives US Patent For Gout/Hyperuricemia Product Formulation Based On Modulation Of The Gut Microbiome With Probiotics And Prebiotics
6/20/2017
-
20 Year Old Kibow Biotech, Inc. Further Validates Enteric Dialysis Concept, With Greater Understanding of Modulating the Gut Microbiome with Pro/Prebiotics Towards Maintaining Healthy Kidney Function
4/24/2017